You are here

  • Home
  • Archive
  • Volume 5, Issue Suppl 2
  • CT-03 Phase 2 trial of induction therapy with anti-CD20 (rituximab) followed by maintenance therapy with anti-BAFF (belimumab) in patients with active lupus nephritis

Article metrics

Article menu

Download PDFPDF

Clinical Trials
CT-03 Phase 2 trial of induction therapy with anti-CD20 (rituximab) followed by maintenance therapy with anti-BAFF (belimumab) in patients with active lupus nephritis
Free

 

Online download statistics by month:

Online download statistics by month: September 2018 to August 2024

AbstractFullPdf
Sep 201846011
Oct 20182405
Nov 20182405
Dec 201838011
Jan 201928002
Feb 201938407
Mar 201945407
Apr 201939006
May 201941703
Jun 201940203
Jul 201940201
Aug 201943602
Sep 201938806
Oct 201936600
Nov 201928202
Dec 20192602
Jan 20202202
Feb 2020702
Mar 2020001
Apr 2020600
May 20201204
Jun 20201201
Jul 20201602
Aug 2020602
Sep 20202401
Oct 20203001
Nov 20201804
Dec 20201001
Jan 20211805
Feb 2021304
Mar 20211002
Apr 2021401
May 2021203
Jun 2021103
Jul 2021001
Aug 2021003
Sep 2021008
Oct 202114014
Nov 20216012
Dec 20211106
Jan 2022502
Feb 2022605
Mar 20222202
Apr 2022403
May 2022906
Jun 2022903
Jul 20221101
Aug 20221802
Sep 2022906
Oct 202214012
Nov 2022601
Dec 20221102
Jan 20231705
Feb 2023700
Mar 20232002
Apr 2023101
May 2023803
Jun 2023401
Jul 2023202
Aug 2023306
Sep 2023203
Oct 2023902
Nov 2023903
Dec 20231001
Jan 20242100
Feb 20241106
Mar 202416033
Apr 20242208
May 2024401
Jun 20241202
Jul 20241203
Aug 20241904
Total49240287